Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040559

EVP, Global Head RA & Quality sold 3,346 shares at an average $1.65 ($5,531)

From the SEC's structured data for this filing

Trades in this filing

Henrich Jill · EVP, Global Head RA & Quality

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Sale : show line 1 in the form −2,788 $1.65 $4,609 108,249 D
2023-08-16 Sale : show line 2 in the form −558 $1.65 $923 107,691 D
Open-market sales · 3,346 sh · avg $1.65 · $5,531
Loading xslF345X05/form4.xml…